BMS 599626 2HCl (873837-23-1(HCl))
CAS No. 1781932-33-9
BMS 599626 2HCl (873837-23-1(HCl))( —— )
Catalog No. M35292 CAS No. 1781932-33-9
BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100-fold to Lck, VEGFR2, c-Kit, MET, etc.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 76 | Get Quote |
|
| 5MG | 107 | Get Quote |
|
| 10MG | 169 | Get Quote |
|
| 25MG | 347 | Get Quote |
|
| 50MG | 513 | Get Quote |
|
| 100MG | 709 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBMS 599626 2HCl (873837-23-1(HCl))
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100-fold to Lck, VEGFR2, c-Kit, MET, etc.
-
DescriptionBMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100-fold to Lck, VEGFR2, c-Kit, MET, etc.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHER/HSP
-
RecptorHER
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1781932-33-9
-
Formula Weight603.48
-
Molecular FormulaC27H29FN8O3Cl2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC[C@@H]1COCCN1)NC2=CN3C(C(NC4=CC=C(N(N=C5)CC6=CC(F)=CC=C6)C5=C4)=NC=N3)=C2C.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Trastuzumab
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
-
Zongertinib
Zongertinib is a human HER2-selective tyrosine kinase inhibitor, a novel TK that is highly selective for covalent binding to the HER2 tyrosine kinase domain (TKD).
-
BENZYLACETONE
Used in soap perfumes.
Cart
sales@molnova.com